Clinical Trials in Rare Diseases
54:57
Description
Master innovative trial designs, patient recruitment, and regulatory strategies in rare disease research.
What You'll Learn?
- Understand the definition and epidemiology of rare diseases and their implications for clinical research.
- Identify and address the challenges of designing and recruiting for clinical trials in rare disease populations.
- Utilize innovative trial designs tailored to the constraints of rare disease research.
- Collaborate effectively with patient associations to enhance recruitment and patient engagement.
- Navigate the specific regulations and guidelines that apply to clinical trials in rare diseases.
Who is this for?
What You Need to Know?
More details
DescriptionThis course is designed to address the unique challenges faced when conducting clinical trials for rare diseases, which affect a small percentage of the population but have a significant impact worldwide. Participants will learn how to navigate these complexities and develop strategies to overcome the barriers in rare disease research.
The course begins with an exploration of the definition and epidemiology of rare diseases, including criteria used globally to define these conditions and their prevalence. The importance of patient registries, such as Orphanet, in providing data for research will be discussed.
Participants will then tackle the challenges in clinical trial design and patient recruitment. Due to small patient populations and geographical dispersion, rare disease trials require innovative strategies to ensure robust trial designs and adequate patient recruitment and retention.
The course emphasizes the use of innovative trial designs that are particularly suited for rare diseases, such as single-arm trials, adaptive designs, and N-of-1 trials, which offer flexibility and personalization to overcome the limitations of traditional trial structures.
A key focus is on collaboration with patient associations, highlighting the importance of patient advocacy groups in recruitment, engagement, and incorporating patient perspectives into research. Effective partnership strategies will also be covered.
Lastly, participants will gain a comprehensive understanding of regulatory and ethical guidelines governing rare disease trials, such as the Orphan Drug Act, and will learn to navigate the regulatory landscape to expedite trial approvals while ensuring ethical treatment of participants.
This course is ideal for clinical researchers, healthcare professionals, and regulatory specialists involved in rare disease trials.
Who this course is for:
- Clinical researchers and professionals involved in rare disease research.
- Healthcare professionals interested in the challenges of rare disease trials.
- Regulatory affairs specialists working with orphan drugs and rare disease clinical trials.
This course is designed to address the unique challenges faced when conducting clinical trials for rare diseases, which affect a small percentage of the population but have a significant impact worldwide. Participants will learn how to navigate these complexities and develop strategies to overcome the barriers in rare disease research.
The course begins with an exploration of the definition and epidemiology of rare diseases, including criteria used globally to define these conditions and their prevalence. The importance of patient registries, such as Orphanet, in providing data for research will be discussed.
Participants will then tackle the challenges in clinical trial design and patient recruitment. Due to small patient populations and geographical dispersion, rare disease trials require innovative strategies to ensure robust trial designs and adequate patient recruitment and retention.
The course emphasizes the use of innovative trial designs that are particularly suited for rare diseases, such as single-arm trials, adaptive designs, and N-of-1 trials, which offer flexibility and personalization to overcome the limitations of traditional trial structures.
A key focus is on collaboration with patient associations, highlighting the importance of patient advocacy groups in recruitment, engagement, and incorporating patient perspectives into research. Effective partnership strategies will also be covered.
Lastly, participants will gain a comprehensive understanding of regulatory and ethical guidelines governing rare disease trials, such as the Orphan Drug Act, and will learn to navigate the regulatory landscape to expedite trial approvals while ensuring ethical treatment of participants.
This course is ideal for clinical researchers, healthcare professionals, and regulatory specialists involved in rare disease trials.
Who this course is for:
- Clinical researchers and professionals involved in rare disease research.
- Healthcare professionals interested in the challenges of rare disease trials.
- Regulatory affairs specialists working with orphan drugs and rare disease clinical trials.
User Reviews
Rating
Udemy
View courses Udemy- language english
- Training sessions 5
- duration 54:57
- English subtitles has
- Release Date 2024/12/03
